MX356444B - Multiple arrangement of specific antibodies for the prognosis, detection and monitoring of the fibrogenic process. - Google Patents

Multiple arrangement of specific antibodies for the prognosis, detection and monitoring of the fibrogenic process.

Info

Publication number
MX356444B
MX356444B MX2013010938A MX2013010938A MX356444B MX 356444 B MX356444 B MX 356444B MX 2013010938 A MX2013010938 A MX 2013010938A MX 2013010938 A MX2013010938 A MX 2013010938A MX 356444 B MX356444 B MX 356444B
Authority
MX
Mexico
Prior art keywords
prognosis
monitoring
detection
multiple arrangement
specific antibodies
Prior art date
Application number
MX2013010938A
Other languages
Spanish (es)
Other versions
MX2013010938A (en
Inventor
Gabriela Gutiérrez Reyes Esperanza
Kershenobich Stalnikowitz David
Original Assignee
Univ Mexico Nac Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mexico Nac Autonoma filed Critical Univ Mexico Nac Autonoma
Priority to MX2013010938A priority Critical patent/MX356444B/en
Priority to PCT/MX2014/000148 priority patent/WO2015047072A1/en
Publication of MX2013010938A publication Critical patent/MX2013010938A/en
Publication of MX356444B publication Critical patent/MX356444B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7052—Fibrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to non-invasive biomarkers coupled to spheres operating as solid supports in a multiple arrangement, used in the detection, prognosis and monitoring of the fibrogenic process.
MX2013010938A 2013-09-24 2013-09-24 Multiple arrangement of specific antibodies for the prognosis, detection and monitoring of the fibrogenic process. MX356444B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2013010938A MX356444B (en) 2013-09-24 2013-09-24 Multiple arrangement of specific antibodies for the prognosis, detection and monitoring of the fibrogenic process.
PCT/MX2014/000148 WO2015047072A1 (en) 2013-09-24 2014-09-24 Multiple arrangement of specific antibodies for the prognosis, detection and monitoring of the fibrogenic process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013010938A MX356444B (en) 2013-09-24 2013-09-24 Multiple arrangement of specific antibodies for the prognosis, detection and monitoring of the fibrogenic process.

Publications (2)

Publication Number Publication Date
MX2013010938A MX2013010938A (en) 2015-03-24
MX356444B true MX356444B (en) 2018-05-21

Family

ID=52744064

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010938A MX356444B (en) 2013-09-24 2013-09-24 Multiple arrangement of specific antibodies for the prognosis, detection and monitoring of the fibrogenic process.

Country Status (2)

Country Link
MX (1) MX356444B (en)
WO (1) WO2015047072A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60026337T2 (en) * 2000-08-21 2007-01-11 Assistance Publique, Hopitaux De Paris METHOD FOR THE DIAGNOSIS OF LIVER ILLNESS, USING BIOCHEMICAL CHARACTERISTICS
US6986995B2 (en) * 2002-02-28 2006-01-17 Prometheus Laboratories, Inc. Methods of diagnosing liver fibrosis
DE602004004775T2 (en) * 2004-08-12 2007-11-22 Roche Diagnostics Gmbh Method for the diagnosis of liver fibrosis.
DE102004052729A1 (en) * 2004-10-30 2006-05-04 Roche Diagnostics Gmbh Immunocomplex-specific antibody for zero-reduction in the detection of antigen-specifically bound antibodies of a specific immunoglobulin class in array test formats

Also Published As

Publication number Publication date
WO2015047072A1 (en) 2015-04-02
MX2013010938A (en) 2015-03-24

Similar Documents

Publication Publication Date Title
WO2014160499A3 (en) Methods and compositions for detecting pancreatic cancer
MX2019005748A (en) Biomarkers related to kidney function and methods using the same.
SG11201703289YA (en) Optical gas concentration measuring method, and method for monitoring gas concentration by said method
EP3176268A4 (en) Novel biomarker for predicting sensitivity to egfr-targeting agent, and use thereof
PL3358356T3 (en) Solution for dissociating vitamin d from vitamin d-binding protein, associated detection method and use
EP3029160A4 (en) Abnormality detection method and blast-furnace operation method
NZ629555A (en) Monocyte biomarkers for cancer detection
EP2970061A4 (en) An improved integrated process to produce 2,3,3,3-tetrafluoropropene
MX358474B (en) Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases.
EP3126846A4 (en) Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
EP2949639A4 (en) Alpha, alpha-difluoroacetaldehyde production method
GB2514602B (en) Method, apparatus and computer program for scheduling device-to-device signals
HUE045124T2 (en) Silane-modified silicic acid, method for the production and use thereof
FR3001463B1 (en) LUMINESCENT CARBON PARTICLES, PROCESS FOR PREPARATION AND USE
EP2956086A4 (en) Electrochemical processing of materials, methods and production
EP2962105A4 (en) Methods and reagents for determining isomeric analytes
EP3176269A4 (en) Novel biomarker for predicting sensitivity to met inhibitor, and use thereof
PL2848901T3 (en) Method of, and apparatus for, monitoring the available resources of a gas cylinder
MX363679B (en) Method of diagnosing cancer.
PL3055679T3 (en) Fissure-detection agent, method for the production thereof and use of the fissure-detection agent
EP2980249A4 (en) Steel plate for thick steel pipe, method for manufacturing same, and high strength thick steel pipe
GB201303168D0 (en) Immunoassay for detecting kratom, Its constituents and their use
WO2016027029A3 (en) Method for determining the survival prognosis of a patient suffering from pancreatic cancer
IN2014DN07191A (en)
MX2013010938A (en) Multiple arrangement of specific antibodies for the prognosis, detection and monitoring of the fibrogenic process.

Legal Events

Date Code Title Description
FG Grant or registration